Objective: To compare the effects of chitosan and orlistat on fecal fat exc
retion.
Research Methods and Procedure: A randomized, open-label, two-period sequen
tial design study was used. A total of 12 healthy adult volunteers within 2
0% of their ideal body weight entered a 7-day run-in diet period before bei
ng randomized to orlistat (120 mg) or chitosan (890 mg) three times daily f
or 7 days. Subjects then crossed over treatment regimens for an additional
7-day period. Subjects followed a standardized diet (2500 kcal/d, 30% as fa
t) for the entire 21-day study. Feces were collected on days 4 to 7 of the
run-in period (baseline) and during the two treatment periods. Mean daily f
ecal fat excretion was measured at baseline and during each treatment regim
en.
Results: Mean baseline fecal fat excretion for all subjects was 1.36 +/- 0.
45 g/d. During orlistat treatment, mean fecal fat excretion significantly i
ncreased from baseline (+16.13 +/- 7.27 g/d; p < 0.001). No significant eff
ect was observed with chitosan (+0.27 +/- 1.02 g/d; p = 0.379). Fecal fat e
xcretion was significantly greater with orlistat than-with chitosan (p < 0.
001; 95% confidence intervals: 11.73; 20.00 g/d).
Discussion: This study provides additional evidence of the inhibitory effec
t of orlistat on dietary fat absorption. Chitosan, however, has no effect o
n fecal fat excretion.